Latest Module
Clinical evidence from pivotal trials of aPCC in the treatment of haemophilia
Patients with long-standing haemophilia who develop inhibitors to their exogenous coagulation factor therapy derive significant event reduction with activated prothrombin complex concentrate(aPCC)
Cardiopulmonary protection in severe respiratory disease
Prof Tsabedze, cardiologist, counts cardiopulmonary protection as an essential action for patients with respiratory disease
Transforming paediatric asthma management: The role of dupilumab in reshaping treatment paradigms
A leading Australian immunologist discusses severe childhood asthma and the value of dupilumab in its management



